Management of Postpartum Anxiety and Depression: A Narrative Review

See Jia Whei, Sheryl Deva, Vetrivel Vijayakumar, Shayaan Sarfaraz Khan, Sarah Ahmed Awad, Ummul Asfeen, Romil Hemal Maniar, Bibek Shrestha
{"title":"Management of Postpartum Anxiety and Depression: A Narrative Review","authors":"See Jia Whei,&nbsp;Sheryl Deva,&nbsp;Vetrivel Vijayakumar,&nbsp;Shayaan Sarfaraz Khan,&nbsp;Sarah Ahmed Awad,&nbsp;Ummul Asfeen,&nbsp;Romil Hemal Maniar,&nbsp;Bibek Shrestha","doi":"10.1002/mhs2.70012","DOIUrl":null,"url":null,"abstract":"<p>Postpartum anxiety and depression are two of the leading causes of maternal morbidity and emerge from being one of the most underdiagnosed and undertreated mental health problems. Its prevalence has been reported to affect about 10%–20% of pregnant women. Due to such large-scale prevalence, the need for better diagnostic techniques and therapeutic management has been addressed in this review. Maternal health largely influences the health of the newborn, affecting not only the growth and development of the child but also the mother-child bond as mothers with postpartum depression reportedly have a lack of interest in their child. Understanding the pathophysiology of the disease including the hormonal factors, the neurotransmitter pathways that become skewed, genetic influences and psychosocial factors, are essential to develop treatment options. This review outlines all the different pathophysiology and theories so far researched in this field. Although significant strides have been made in developing diagnostic and therapeutic management, the need for further research and testing is emphasized. Unfortunately, research testing the safety of several antidepressant classes that can be used to treat postpartum anxiety, and depression cannot be undertaken due to the major ethical issues it raises in conducting such research in pregnant women. This review highlights the promising avenues of further research that have the potential to treat and prevent this debilitating disease. Using biomarkers for early detection, the field of pharmacogenomics which helps to tailor prescriptions for personalized treatment, and pharmacological treatments which include antidepressants like serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors and various nonpharmacological measures including massages, psychotherapy, co-parenting, postnatal exercises, kangaroo care, and music remedies, have been discussed. Finally, the role of public education in highlighting the prevention of stigma surrounding postpartum anxiety and depression has been addressed.</p>","PeriodicalId":94140,"journal":{"name":"Mental health science","volume":"3 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mhs2.70012","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mental health science","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/mhs2.70012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Postpartum anxiety and depression are two of the leading causes of maternal morbidity and emerge from being one of the most underdiagnosed and undertreated mental health problems. Its prevalence has been reported to affect about 10%–20% of pregnant women. Due to such large-scale prevalence, the need for better diagnostic techniques and therapeutic management has been addressed in this review. Maternal health largely influences the health of the newborn, affecting not only the growth and development of the child but also the mother-child bond as mothers with postpartum depression reportedly have a lack of interest in their child. Understanding the pathophysiology of the disease including the hormonal factors, the neurotransmitter pathways that become skewed, genetic influences and psychosocial factors, are essential to develop treatment options. This review outlines all the different pathophysiology and theories so far researched in this field. Although significant strides have been made in developing diagnostic and therapeutic management, the need for further research and testing is emphasized. Unfortunately, research testing the safety of several antidepressant classes that can be used to treat postpartum anxiety, and depression cannot be undertaken due to the major ethical issues it raises in conducting such research in pregnant women. This review highlights the promising avenues of further research that have the potential to treat and prevent this debilitating disease. Using biomarkers for early detection, the field of pharmacogenomics which helps to tailor prescriptions for personalized treatment, and pharmacological treatments which include antidepressants like serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors and various nonpharmacological measures including massages, psychotherapy, co-parenting, postnatal exercises, kangaroo care, and music remedies, have been discussed. Finally, the role of public education in highlighting the prevention of stigma surrounding postpartum anxiety and depression has been addressed.

Abstract Image

产后焦虑和抑郁的管理:一个叙述性的回顾
产后焦虑和抑郁是孕产妇发病率的两大主要原因,也是诊断和治疗最不充分的精神健康问题之一。据报道,约有 10%-20%的孕妇受其影响。由于其发病率如此之高,本综述探讨了对更好的诊断技术和治疗管理的需求。产妇的健康在很大程度上影响着新生儿的健康,不仅会影响孩子的生长发育,还会影响母子关系,因为据报道,患有产后抑郁症的母亲对孩子缺乏兴趣。了解产后抑郁症的病理生理学,包括荷尔蒙因素、发生偏移的神经递质通路、遗传影响和社会心理因素,对于制定治疗方案至关重要。本综述概述了该领域迄今为止研究的所有不同病理生理学和理论。虽然在诊断和治疗管理方面取得了长足进步,但仍强调需要进一步的研究和测试。遗憾的是,由于在孕妇中开展此类研究会引发重大伦理问题,因此无法对可用于治疗产后焦虑症和抑郁症的几类抗抑郁药物的安全性进行测试。本综述强调了有可能治疗和预防这种使人衰弱的疾病的前景广阔的进一步研究途径。本综述讨论了利用生物标志物进行早期检测、药物基因组学领域(该领域有助于为个性化治疗量身定制处方)、药物治疗(包括抗抑郁药物,如血清素再摄取抑制剂、血清素去甲肾上腺素再摄取抑制剂)以及各种非药物措施(包括按摩、心理治疗、共同养育、产后锻炼、袋鼠式护理和音乐疗法)。最后,还讨论了公众教育在预防产后焦虑症和抑郁症耻辱化方面的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信